Nobel laureate says he previously considered himself a supporter of Israel, but ‘the campaign of annihilation in Gaza has changed all that’ Nobel laureate JM Coetzee has declined to attend an upcoming literature festival in Israel, writing a excoriating letter to organisers citing the country’s “genocidal campaign” in Gaza, stating: “It will take many years for Israel to clear its name”. The 86-ye...
Nobel laureate says he previously considered himself a supporter of Israel, but ‘the campaign of annihilation in Gaza has changed all that’ Nobel laureate JM Coetzee has declined to attend an upcoming literature festival in Israel, writing a excoriating letter to organisers citing the country’s “genocidal campaign” in Gaza, stating: “It will take many years for Israel to clear its name”. The 86-year-old author, who was born in apartheid South Africa and lives in Australia, wrote to organisers of the Jerusalem international writers festival in November. Continue reading...
Viridian Therapeutics ( VRDN ) priced upsized concurrent public offerings totaling $350M in gross proceeds, including $225M of 1.75% convertible senior notes due 2032 and $125M of common stock. The convertible notes will mature on May 15, 2032, unless earlier converted, redeemed, or repurchased. The initial conversion price is about $24.65 per share, representing a 45% premium to the common stock ...
Viridian Therapeutics ( VRDN ) priced upsized concurrent public offerings totaling $350M in gross proceeds, including $225M of 1.75% convertible senior notes due 2032 and $125M of common stock. The convertible notes will mature on May 15, 2032, unless earlier converted, redeemed, or repurchased. The initial conversion price is about $24.65 per share, representing a 45% premium to the common stock offering price. Net proceeds are expected to be about $334.7M, and the company plans to use it to repay outstanding debt under its agreement with Hercules Capital, support market expansion studies for its thyroid eye disease franchise, advance earlier-stage pipeline programs, and for general corporate purposes. The offerings are expected to close on May 11, 2026. The stock price traded 1.25% lower on Wednesday during after-market hours. More on Viridian Therapeutics Viridian Therapeutics, Inc. (VRDN) Discusses Positive Top Line Results From REVEAL-2 Phase III Trial in Chronic Thyroid Eye Disease Transcript Viridian Therapeutics: Why Elegrobart Phase 3 Results Fail To Challenge Amgen Amgen's Thyroid Eye Disease Data Rocks Rival Viridian, Makes It The Better Buy Viridian soars on top-line phase 3 data for elegrobart in thyroid eye disease Viridian Therapeutics launches $250M concurrent debt and equity offerings
(RTTNews) - German specialty chemicals company Lanxess AG (LNXSF.PK) reported Thursday wider net loss and weak adjusted EBITDA in its first quarter, hurt by lower revenues. The company noted that a persistently weak economic environment, ongoing geopolitical uncertainties and pri
(RTTNews) - German specialty chemicals company Lanxess AG (LNXSF.PK) reported Thursday wider net loss and weak adjusted EBITDA in its first quarter, hurt by lower revenues. The company noted that a persistently weak economic environment, ongoing geopolitical uncertainties and pri
(RTTNews) - European stocks are seen opening mixed on Thursday after posting strong gains in the previous session on optimism over a potential U.S.-Iran peace deal and easing concerns about inflationary pressures.
(RTTNews) - European stocks are seen opening mixed on Thursday after posting strong gains in the previous session on optimism over a potential U.S.-Iran peace deal and easing concerns about inflationary pressures.
DEMIRE remains operationally stable in the first quarter of 2026, guidance conf., rental income EUR 11.6m (prev EUR 14.0m), FFOI EUR 0.3m (prev EUR 2.1m)
DEMIRE remains operationally stable in the first quarter of 2026, guidance conf., rental income EUR 11.6m (prev EUR 14.0m), FFOI EUR 0.3m (prev EUR 2.1m)
The following is an extract from the “Iveco Group 2026 First Quarter Results” press release ( *) . The complete press release can be accessed by visiting the media section of the Iveco Group corporate website: https://www.ivecogroup.com/media/corporate_press_releases or consulting the accompanying PDF:
The following is an extract from the “Iveco Group 2026 First Quarter Results” press release ( *) . The complete press release can be accessed by visiting the media section of the Iveco Group corporate website: https://www.ivecogroup.com/media/corporate_press_releases or consulting the accompanying PDF:
New Berkshire CEO Greg Abel has called Coke one of its “core four” investments, along with Apple, Moody’s, and American Express. It’s beating the S&P 500 this year.
New Berkshire CEO Greg Abel has called Coke one of its “core four” investments, along with Apple, Moody’s, and American Express. It’s beating the S&P 500 this year.